[1]. DeHaven-Hudkins DL, et al. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharmacol Exp Ther. 1999 Apr;289(1):494-502.
[2]. Quinney SK, et al. Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. J Pharmacol Exp Ther. 2005 Jun;313(3):1011-6.
[3]. Church J, et al. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Mol Pharmacol,?994, 45(4), 747-757.
[4]. Menéndez L, et al. Analgesic effects of loperamide in bone cancer pain in mice. Pharmacol Biochem Behav. 2005 May;81(1):114-21.